Table 1.
peptides monitored by MRM
| Target | Q1 | Q3 | DP | CE | Peptide | Ion | CV(%) |
|---|---|---|---|---|---|---|---|
| Albumin | 575.3 | 937.5 | 70 | 25 | LVNEVTEFAK | y8 | 5.2 |
| Apo B-100 | 524.3 | 450.8 | 55 | 28 | FPEVDVLTK | y82+ | 20 |
| Apo A-I | 405.9 | 522.3 | 52 | 18 | ATEHLSTLSEK | y9 | 3.2 |
| Apo A-I | 405.9 | 572.8 | 52 | 19 | ATEHLSTLSEK | y102+ | 1.2 |
| M148 | 516.3 | 416.2 | 60 | 30 | LSPLGEEMR | y72+ | 1.5 |
| M+148(O)=M148 + 16 | 524.3 | 424.4 | 60 | 27 | LSPLGEEM(O)R | y72+ | 3.8 |
| M+148(O)=M148 + 16 | 524.3 | 637.3 | 60 | 33 | LSPLGEEM(O)R | y5 | 4.2 |
| M+148(O)=M148 + 16 | 524.3 | 750.4 | 60 | 33 | LSPLGEEM(O)R | y6 | 4.7 |
The CVs were calculated from 8 replicate analyses of a control sample.
DP: Declustering Potential.
CE: Collision Energy.
CV: Coefficient of variation.